Obagi

Type: Company

Name: Obagi

First reported May 18 2013 - Updated May 18 2013 - 1 reports

Re-entering the Fray for Beauty Products

Valeant's victory of Obagi portends a larger trend where competition is likely to intensify among strategic buyers in the cosmetics space ... [Published Mergers & Acquisitions - May 18 2013]

Entities: Beauty Products, Obagi, Valeant Pharmaceuticals International

First reported May 17 2013 - Updated May 17 2013 - 1 reports

Harmless Eyes

Exposure to the sun, leads to enhancement of facial lines, the harmful sun from infiltrating our bodies. best anti aging products Shop around by finding out what on the skin for ten to fifteen min's, then wash the fruit juice using warm water and softly ... [Published Al Bawaba - May 17 2013]

Entities: Skincare, Anti-Aging, Epidermis

First reported May 15 2013 - Updated May 15 2013 - 1 reports

Actavis

Valeant Pharmaceuticals Intl Inc (VRX), Actavis Inc (ACT): How Would A Combined Company Look?

News that Montreal-based Valeant Pharmaceuticals Intl Inc (NYSE: VRX ) was in talks to merge with Parsippany, New Jersey-based Actavis Inc (NYSE: ACT ) emerged barely a week after the completion of the company’s tender offer for Obagi Pharmaceuticals ... [Published InsiderMonkey.com - May 15 2013]

Entities: VALEANT PHARMACEUTICALS INTERNATIONAL, INC., Actavis, Teva Pharmaceutical Industries Ltd

First reported May 15 2013 - Updated May 15 2013 - 1 reports

Motley Fool

Following Up an Acquisition With an Even Larger Merger?

Mike is a member of The Motley Fool Blog Network -- entries represent the personal opinion of the blogger and are not formally edited.News that Montreal-based Valeant Pharmaceuticals (NYSE: VRX)Over the past year, Valeant has been engaged in an aggressive ... [Published Motley Fool - May 15 2013]

Entities: Valeant Pharmaceuticals International, Motley Fool, Dermatology, Actavis

First reported May 13 2013 - Updated May 13 2013 - 1 reports

Celebrity Dermatologist Zein Obagi's ZO Skin Health Arrives in Singapore

Think you know everything about skincare? The new line of ZO Skin health will challenge everything you've ever learnedCelebrity dermatologist Dr. Zein Obagi has unkind words for the cosmetic industry and their penchant for developing products with outlandish ... [Published XinMsn - May 13 2013]

Entities: Skincare, dermatologist, Singapore, Celebrity

First reported May 13 2013 - Updated May 13 2013 - 1 reports

Solta Medical Inc

Voce Capital Disagrees with Solta Medical's Plan to Double Authorized Share Count

Voce Capital Management has announced its opposition to the proposal by Solta Medical, Inc. to double its authorized shares of common stock to 200,000,000, which will be voted on at the annual meeting on June 5 In a letter recently to Solta's Board, Voce ... [Published Individual.com - May 13 2013]

Entities: Voce, Solta Medical Inc, Acquisition, Obagi, Synergism

First reported May 09 2013 - Updated May 09 2013 - 1 reports

"Merz in $400M bidding war for dermatology firm Obagi"

In the April 5th edition of the Triad Business Journal, Corporate attorney Bob Baynes discusses the difference between a strategic buyer and a financial buyer in an article entitled, "Merz in $400M bidding war for dermatology firm Obagi."Read an exce ... [Published Nexsen Pruet - May 09 2013]

Entities: Obagi, Dermatology, American Bar Foundation, Mergers & Acquisitions, Valeant Pharmaceuticals International

First reported May 07 2013 - Updated May 07 2013 - 1 reports

Celebrity Dermatologist Zein Obagi's ZO Skin Health Arrives in Singapore

Celebrity dermatologist Dr. Zein Obagi has unkind words for the cosmetic industry and their penchant for developing products with outlandish claims for miraculous results. "You are destroying your own skin," he proclaimed at a recent seminar and skincare ... [Published Lifestyle Asia - May 07 2013]

Entities: Skincare, dermatologist, Singapore, Celebrity

First reported May 01 2013 - Updated May 01 2013 - 1 reports

More women are battling acne even as they get wrinkles

It starts with Clearasil, then moves on to stronger stuff: birth control pills, antibiotics, Retin-A, or the nuclear option, Accutane.These days, there's an arsenal of treatments for that common adolescent scourge, acne vulgaris, and the beleaguered teenager ... [Published Kitsap Sun - May 01 2013]

Entities: Obagi, treatments, Benzoyl peroxide, Accutane

First reported Apr 29 2013 - Updated Apr 29 2013 - 2 reports

More adults battling acne breakouts

Entities: Antibiotic, Acne Vulgaris, treatments

First reported Apr 25 2013 - Updated Apr 25 2013 - 2 reports

Valeant Pharmaceuticals International, Inc. Completes Tender Offer for Obagi Medical Products, Inc.

/PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant") today announced the expiration of the tender offer (the "Offer") by a subsidiary of Valeant Pharmaceuticals International ("VPI") to purchase all of the outstanding ... [Published NewsBlaze - Apr 25 2013]

Entities: Obagi, Obagi Medical Products Inc, Tender Offer, Valeant Pharmaceuticals International

First reported Apr 23 2013 - Updated Apr 23 2013 - 1 reports

Valeant Receives Extension of Expiration Date for Tender Offer of Obagi

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) announced it has extended the expiration date of the tender offer by its indirect wholly-owned subsidiary, Odysseus Acquisition Corp., for all of the outstanding shares of common stock of Obagi Medical ... [Published Benzinga.com - Apr 23 2013]

Entities: Obagi, Tender Offer, Valeant Pharmaceuticals International

Quotes

...of how to restore skin health, increase cellular activity and function, and how to improve the skin's ability to be more tolerant," says Dr. Obagi. "The skin is the body's largest organ and I want to show that everyone can have improved quality, vitality and healthy skin."

ZO Skin Health, Inc. Sponsors Dr. Obagi's Comprehensive Educational Suite Of Programs On The Scie ... [Published PR Newswire - May 22 2013]

..."Sun exposure is one of the commonest causes, leading to solar lentigines (the technical term)," Dr Sam Bunting tells us. "Sun exposure can also trigger melasma, which frequently occurs on a background of hormonal change (like the Pill or pregnancy)."

Patching up: the causes and cures of hyperpigmentation [Published Get the Gloss - May 20 2013]

"We have established the concept of stabilization, which serves to increase skin strength and tolerance, even with age" he explained...

Celebrity Dermatologist Zein Obagi's ZO Skin Health Arrives in Singapore [Published XinMsn - May 13 2013]

J. Daniel Plants, Voce's Managing Partner, added upon the sending of today's letter, "rather than writing Solta a blank check to continue acquiring companies with its perennially depressed stock price - precisely what a vote in favor of this proposal will do - we believe there is a far better alternative."

Voce Capital Disagrees with Solta Medical's Plan to Double Authorized Share Count [Published Individual.com - May 13 2013]

More Content

sort by: Date \| Relevance
ZO Skin Health, Inc. Sponsors Dr. Obagi's Compr... [Published PR Newswire - May 22 2013]
Patching up: the causes and cures of hyperpigme... [Published Get the Gloss - May 20 2013]
Re-entering the Fray for Beauty Products [Published Mergers & Acquisitions - May 18 2013]
New Face Facts TV Segment Shared Latest Med Spa... [Published Digital Journal - May 17 2013]
Harmless Eyes [Published Al Bawaba - May 17 2013]
Valeant Pharmaceuticals Intl Inc (VRX), Actavis... [Published InsiderMonkey.com - May 15 2013]
Following Up an Acquisition With an Even Larger... [Published Motley Fool - May 15 2013]
Celebrity Dermatologist Zein Obagi's ZO Skin He... [Published XinMsn - May 13 2013]
Voce Capital Disagrees with Solta Medical's Pla... [Published Individual.com - May 13 2013]
Tampa's Fusion Medispa Announces Their Mother's... [Published PRWeb - May 10 2013]
"Merz in $400M bidding war for dermatology firm... [Published Nexsen Pruet - May 09 2013]
Celebrity Dermatologist Zein Obagi's ZO Skin He... [Published Lifestyle Asia - May 07 2013]
Doctors Take You Behind the Scenes of Their Cle... [Published PRWeb - May 06 2013]
Valeant Pharmaceuticals International, Inc. Com... [Published NewsRX - May 03 2013]
More women are battling acne even as they get w... [Published Kitsap Sun - May 01 2013]
Firm, Tight Skin In Less Than 30 Days [Published Article Motron - Apr 30 2013]
Vero Beach Plastic Surgeon Performs Facelifts f... [Published Live-PR.com - Apr 30 2013]
Vero Beach Plastic Surgeon Performs Facelifts f... [Published Interest!ALERT - Apr 30 2013]
More adults battling acne breakouts [Published Individual.com - Apr 29 2013]
Monday Deal Review: April 29, 2013 [Published The Cross-Border Biotech Blog - Apr 29 2013]
More and more women are battling breakouts that... [Published Pittsburgh Post-Gazette - Apr 29 2013]
Valeant Said to Be in Merger Talks With Rival A... [Published Washington Post - Apr 27 2013]
Valeant in Talks With Actavis on Merger of Gene... [Published Bloomberg - Apr 27 2013]
More » Beauty Encounter Announces Addition of N... [Published Yahoo! News - Apr 25 2013]
Valeant Pharmaceuticals International, Inc. Com... [Published Street Insider - Apr 25 2013]
Valeant Pharmaceuticals International, Inc. Com... [Published NewsBlaze - Apr 25 2013]
Valeant Pharmaceuticals International, Inc. Com... [Published Canada NewsWire - Apr 25 2013]
4 Healthcare Stock Stories Prescribed for Inves... [Published Wall St. Cheat Sheet - Apr 24 2013]
Valeant Receives Extension of Expiration Date f... [Published Benzinga.com - Apr 23 2013]
Monday Deal Review: April 22, 2013 [Published The Cross-Border Biotech Blog - Apr 22 2013]

Blogs

sort by: Date \| Relevance
Monday Deal Review: April 29, 2013 [Published The Cross-Border Biotech Blog - Apr 29 2013] Welcome to your Monday Biotech Deal Review for April 29, 2013! This week saw Ergoresearch and Amorfix close their previously announced private offerings. Trimel, meanwhile, has raised $40 million from their public offering of 50,000,000 common shares. ...
4 Healthcare Stock Stories Prescribed for Inves... [Published Wall St. Cheat Sheet - Apr 24 2013] AstraZeneca Group ( NYSE:AZN ): Closing price $51.94 BIND Therapeutics and AstraZeneca announced that they will work jointly to develop and commercialize an Accuri, which is a targeted and programmable cancer nanomedicine from BIND’s Medicinal Nanoengineering ...
Monday Deal Review: April 22, 2013 [Published The Cross-Border Biotech Blog - Apr 22 2013] Welcome to your Monday Biotech Deal Review for April 22, 2013! Aeterna Zentaris has had a busy two weeks on the commercial front, signing agreements with Merck and Ergomed. However, there was a lot more action as well. Hit the break to catch up on ...
Stocks to Watch: Lufkin, Obagi, Constellation B... [Published WSJ.com: MarketBeat - Apr 08 2013] Among the companies with shares expected to actively trade in Monday's session are Lufkin Industries, Obagi Medical Products and Constellation Brands. ...
Monday Deal Review: April 8, 2013 [Published The Cross-Border Biotech Blog - Apr 08 2013] Welcome to your Monday Biotech Deal Review for April 8, 2013! After a hiatus last week due to the holiday, this week we have a lot of activity to cover. Valeant, in particular has been quite busy, being forced to up their bid for Obagi to $24.00 in ...

Press Releases

sort by: Date \| Relevance
ZO Skin Health, Inc. Sponsors Dr. Obagi's Compr... [Published PR Newswire - May 22 2013]
Merz Pharma Group Withdraws Proposal to Acquire... [Published Financial Services - Apr 08 2013]
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifi... [Published GlobeNewswire: Advertising News - Apr 03 2013]
The Dow Jones Hits New Record. Merz Pharma Grou... [Published Financial Services - Apr 03 2013]
Obagi Medical Products, Inc. and Valeant Pharma... [Published Business Wire Professional Services News - Apr 03 2013]